BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gen-Probe Incorporated (Acquired by Hologic) 

10210 Genetic Center Drive

San Diego  California  92121-4362  U.S.A.
Phone: 858-410-8000 Fax: 858-410-8625


SEARCH JOBS
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people.

 Key Statistics


Email: IR@gen-probe.com
Ownership: Public

Web Site: Gen-Probe Incorporated (Acquired by Hologic)
Employees: 700
Symbol: GPRO
 



Industry
Biotechnology


Collaborations

DiagnoCure  In November 2003, Gen-Probe signed a license and collaboration agreement with DiagnoCure under which the companies are developing, and Gen-Probe will market, an innovative urine test to detect a new, highly specific genetic marker for prostate cancer called PCA3.

Corixa Corporation  In January 2005, Gen-Probe signed an agreement with Corixa to license rights to develop molecular diagnostic tests for approximately 50 potential genetic markers in the areas of prostate, ovarian, cervical, kidney, lung and colon cancer.

AdnaGen  In January 2005, Gen-Probe signed an agreement with AdnaGen, a private company based in Germany, to license AdnaGen's innovative "immunocapture" technology. The technology may help increase the accuracy of molecular diagnostic tests to detect prostate and other cancers, help determine the aggressiveness of these malignancies, and monitor responses to therapy.

bioMerieux, Inc.  In September 2004, Gen-Probe entered into non-exclusive licensing agreements with bioMérieux and its affiliates that provide bioMérieux options to access our ribosomal RNA technologies to develop diagnostic products for certain disease targets.

Roche  In February 2005, Gen-Probe signed a supply and purchase agreement with F. Hoffmann-La Roche Ltd. and its affiliate Roche Molecular Systems, Inc. under which Gen-Probe will purchase products for use in molecular diagnostic assays for human papillomavirus (HPV).

Qualigen, Inc.  In November 2004, Gen-Probe acquired from Qualigen an exclusive option to develop a point-of-use nucleic acid testing (NAT) instrument based on Qualigen's FDA-approved FastPack® immunoassay system.

Tosoh Corporation  In December 2003, Gen-Probe entered into agreements with Tosoh Corporation to cross-license intellectual property covering certain NAT technologies. The licenses cover products in clinical diagnostics and other related fields.

Rebio Gen, Inc.  In July 2001, Gen-Probe entered into a license agreement with Chugai Diagnostics Science Co., Ltd., which was later acquired by Fujirebio and re-named Rebio Gen, Inc. The agreement offers a non-exclusive license for Japan in the field of human clinical diagnostics to various of our proprietary technologies.





 Company News
Ex Gen-Probe Incorporated (Acquired by Hologic) (GPRO) CEO Embarks On New $300 Million Venture 3/20/2014 7:42:38 AM    More...
Hologic, Inc. (HOLX) Cuts Gen-Probe Incorporated (Acquired by Hologic) (GPRO) CEO Loose as Merger Speeds Ahead 1/23/2013 8:44:10 AM    More...
Becton, Dickinson and Company (BDX) Settles Gen-Probe Incorporated (Acquired by Hologic) (GPRO) Beef 12/5/2012 8:08:23 AM    More...
Gen-Probe Incorporated (GPRO) Receives Stockholder Approval for Proposed Merger With Hologic, Inc. (HOLX) 8/1/2012 10:04:45 AM    More...
Hologic, Inc. (HOLX) Completes Acquisition of Gen-Probe Incorporated (GPRO) 8/1/2012 9:53:37 AM    More...
Gen-Probe Incorporated (GPRO) and Life Technologies (LIFE) to Co-Distribute SeCore® HLA Sequence-Based Typing Products 7/24/2012 10:08:13 AM    More...
Hologic, Inc. (HOLX) Announces Pricing of Financing in Connection With Acquisition of Gen-Probe Incorporated (GPRO) 7/19/2012 10:10:22 AM    More...
Hologic, Inc. (HOLX) and Gen-Probe Incorporated (GPRO) Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe 7/17/2012 9:53:52 AM    More...
Hologic, Inc. (HOLX) to Pay Gen-Probe Incorporated (GPRO) CEO $6.9 Million to Stay on Board 7/12/2012 10:25:35 AM    More...
Hologic, Inc. (HOLX) and Gen-Probe Incorporated (GPRO) Announce Expiration of Hart-Scott-Rodino Act Waiting Period 6/19/2012 10:36:20 AM    More...
12345678910...

//-->